OVID

Ovid Therapeutics Inc. Common Stock (OVID)

Stock · NASDAQ · Health Care

$2.8as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$2.38
Industry
Biotechnology: Pharmaceutical Preparations

Ovid Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • OVID
    Ovid Therapeutics Inc. Common Stock
    $2.81
    ▼ 4.10%
    Market cap $434.87MP/E
  • PRTA
    Prothena Corporation plc Ordinary Shares
    $9.35
    ▲ 2.86%
    Market cap $436.10MP/E
    $7.73$11.8
  • SGMT
    Sagimet Biosciences Inc. Series A Common Stock
    $10.55
    ▼ 1.86%
    Market cap $441.53MP/E
    $4.5$11.15
  • QTTB
    Q32 Bio Inc. Common Stock
    $15.01
    ▼ 7.06%
    Market cap $451.37MP/E 15.71
    $1.62$23.57
  • BNTC
    Benitec Biopharma Inc. Common Stock
    $12.51
    ▼ 1.30%
    Market cap $417.41MP/E
    $9.85$16.76
  • KMDA
    Kamada Ltd. Ordinary Shares
    $8.29
    ▲ 0.36%
    Market cap $417.07MP/E 20.65
    $6.5$9.35
  • LRMR
    Larimar Therapeutics Inc. Common Stock
    $4
    ▼ 1.23%
    Market cap $413.45MP/E
    $2.72$6.42

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
104.64M
Total value held
$231.92M
Institutional holders
100
Top holders this quarter
  • Unknown10.71M
  • Unknown10.71M
  • Unknown10.64M
  • Unknown9.92M
  • Unknown6.16M
  • Unknown5.53M
  • Unknown5.26M
  • Unknown4.54M
  • Unknown4.17M
  • Unknown3.57M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.